Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Immunosuppressive treatments in multiple sclerosis.
Higher burden of migraine compared to other neurological conditions: results from a cross-sectional study.
Systematic review of occupational therapy-related interventions for people with multiple sclerosis: part 2. Impairment.
Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States.
CD226 Gly307Ser association with multiple autoimmune diseases: A meta-analysis.
Cerebral white matter blood flow and energy metabolism in multiple sclerosis.
Clinical predictors of an optimal response to natalizumab in multiple sclerosis.
Comment on Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin.
Tumefactive demyelinating lesions: A Clinicopathological correlative study.
MHC Mismatch Results in Neural Progenitor Cell Rejection Following Spinal Cord Transplantation in a Model of Viral-Induced Demyelination.
Statistical normalization techniques for magnetic resonance imaging.
The effect of scheduled antibody testing on treatment patterns in interferon-treated patients with multiple sclerosis.
Diet, microbiota and autoimmune diseases.
Neuromyelitis optica in children: a review of the literature.
Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient.
Cognitive correlates of under-ambiguity and under-risk decision making in high-functioning patients with relapsing remitting multiple sclerosis.
Where is the causal variant? On the advantage of the family design over the case-control design in genetic association studies.
Activation of the Nrf2 Cell Defense Pathway by Ancient Foods: Disease Prevention by Important Molecules and Microbes Lost from the Modern Western Diet.
Psychosocial, Affective, and Behavioral Consequences of Multiple SclerosisTreatment of the "Whole" Patient.
To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis.
Primary varicella zoster infection associated with fingolimod treatment.
An Increase in Tolerogenic Dendritic Cell and Natural Regulatory T Cell Numbers during Experimental Autoimmune Encephalomyelitis in Rras-/- Mice Results in Attenuated Disease.
Body composition in multiple sclerosis.
Neuromyelitis Optica Preceded by HyperCKemia and a Possible Association with Coxsackie Virus Group A10 Infection.
Association of urodynamic findings in new onset multiple sclerosis with subsequent occurrence of urinary symptoms and acute episode of disease in females.
Pages
« first
‹ previous
…
284
285
286
287
288
289
290
291
292
…
next ›
last »